University of NebraskaOmaha, Nebraska, United States
National Institute of Allergy and Infectious Diseases , NIH (Grant/Research Support)
LB2 - Safety and Efficacy of Combination SARS-CoV-2 Monoclonal Neutralizing Antibodies (mAb) BRII-196 and BRII-198 in Non-Hospitalized COVID-19 Patients
Thursday, September 30, 20215:30 PM - 5:45 PM EDT